Robert Lehn, MD
Pain Medicine · Portsmouth, NHNPI 1386971901
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,808 of the $9,319 with a category attached, or 73.0%. It is spread thinly across 42 manufacturers, the largest accounting for just 18.8%. Reporting peaked in 2022 at $3,238 and has fallen 93.8% since, to $202 in 2025.
Across 216 payments — averaging $43.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Spinal Simplicity, LLC$924
- Medtronic$826
- Painteq LLC$783
- Pacira Pharmaceuticals Incorporated$440
- Boston Scientific$394
- plus $4K from 36 others
What the payments were for
- Travel & lodging$2,49927%
- Food & beverage$6,80873%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$1,601
- HA MINUTEMAN G3-R$768
- Intracept$611
- SYNCHROMED$496
- EXPAREL$232
- Stimrouter Implantable Kit$178
- EVOS$161
- LINVATEC HIP PRESERVATION SYSTEM$149
- HALL POWER$149
- LINVATEC SHOULDER ARTHROSCOPY$149
- Durolane$147
- WaveWriter Alpha Prime 16$130
- BELBUCA$123
- Iovera$123
- RENASYS TOUCH$119
- PICO 7$119
- RENASYS GO v2 HOME$119
- Physio-Stim$110
- Gel One$106
- SCP Bone Substitute$106
How this compares
$9,319 in reported general payments places this provider in the 80th percentile of 38 pain medicine providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 570 | $7,748 |
| Duloxetine Hcl | 164 | $3,876 |
| Pregabalin | 35 | $1,182 |
| Prednisone | 326 | $551 |
| Nortriptyline Hcl | 32 | $526 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 61 | $340 |
| Celecoxib | 15 | $292 |
| Oxycodone Hcl | 29 | $68 |
| Tramadol Hcl | 30 | $62 |
| Cyclobenzaprine Hcl | 17 | $62 |
| Clindamycin Hcl | 29 | $55 |
| Meloxicam | 18 | $46 |
| Diazepam | 29 | $37 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Portsmouth
- Joshua GreenspanPortsmouth$6K
- Barry GendronPortsmouth$632
- Praveen SuchdevNashua$72K
- Zubin BatlivalaBedford$18K
- Bert FichmanLebanon$15K
- Dennis ThapaDover$13K
- Michael BovaLebanon$12K
- James MirazitaNashua$10K
- Thomas ZoukiDover$9K
- Edward DohertyNashua$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.